NIH-funded research R21 grant

Understanding how a specific protein in Chlamydia affects its growth and development

Official title: Characterizing the Function of the Periplasmic Protease Tsp in Chlamydial Secondary Differentiation

Funded at University of Nebraska Medical Center · NIH-10792639 · Data updated 2026-11-12

This study is looking at a specific protein in Chlamydia to see how it helps the bacteria grow and change inside our bodies, which could lead to new ways to understand and treat infections caused by this germ.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Nebraska Medical Center
NIH-funded
Lab location1 site (Omaha, United States)
Project startFebruary 21, 2023
Project endJanuary 31, 2026
Funding year2024
Award (this year)$188,875
NIH project number5R21AI171228-02
Project IDNIH-10792639 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over 21 years old who may be at risk for Chlamydia infections or related complications.

Less likely to help

Patients who are not at risk for Chlamydia infections or those who have already been effectively treated for such infections may not benefit from this research.

What this research studies

This research investigates the role of the periplasmic protease Tsp in the life cycle of Chlamydia, a bacterium responsible for various serious infections, including sexually transmitted infections and preventable blindness. By examining how this protein influences Chlamydia's ability to differentiate and adapt within host cells, the study aims to uncover new insights into the pathogen's biology. The approach involves detailed biological and cellular analyses to understand the mechanisms behind Chlamydia's development and its interactions with human cells.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for diagnosing and treating Chlamydia infections, potentially reducing the incidence of related diseases.

How similar studies have gone: While research on Chlamydia has been extensive, the specific focus on the Tsp protease is relatively novel, suggesting potential for new discoveries.

Where this research is happening

  • University of Nebraska Medical Center
    Omaha, United States
    Active

Researchers

  • Principal investigator: Ouellette, Scot P — University of Nebraska Medical Center
  • Study coordinator: Ouellette, Scot P

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.